Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia?
Internal Medicine
[키워드] acute respiratory distress
acute respiratory syndrome
antibody
anticoagulation
arterial thromboembolic event
Atrial fibrillation
cause
coronavirus
coronavirus disease
cough
Course
COVID-19
COVID-19 patient
described
develop
diagnose
diagnosed
Factor
fatigue
Fever
heparin induced thrombocytopenia
heparin-induced thrombocytopenia
hospital
hypercoagulability
independent risk factor
life-threatening
LMWH
low molecular weight
low molecular weight heparin
manifestation
mural arch thrombus
pandemic
Patient
Pneumonia
required
SARS-CoV-2
syndrome
the disease
therapeutic
thromboembolic complication
Thrombus
treated
Treatment
unfractionated heparin
venous
viral respiratory
WHO
with COVID-19
World Health Organization
Wuhan, China
[DOI] 10.7759/cureus.13425 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.13425 PMC 바로가기 [Article Type] Internal Medicine